23vPS

BIOLOGICAL2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer

Conditions

Pneumococcal InfectionsVaccines, Pneumococcal Conjugate Vaccine

Phase 3

Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)

CompletedNCT00546572

Wyeth is now a wholly owned subsidiary of PfizerPneumococcal Infections

Start: 2007-11-30End: 2010-07-31Updated: 2011-07-14

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

CompletedNCT00980655

PfizerVaccines, Pneumococcal Conjugate Vaccine

Start: 2010-01-18End: 2013-05-16Updated: 2018-12-20

Related Papers

Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study

Clinical Infectious Diseases2015-04-13102 citations